$Use of fractional dose tetravalent A, C, W135 and Y meningococcal polysaccharide vaccine: A non inferiority trial$

Use of fractional dose tetravalent A, C, W135 and Y meningococcal polysaccharide vaccine: A non inferiority trial

Bibliographic Details
Main Authors:	Guerin, P, Naess, L, Fogg, C, Rosenqvist, E, Pinoges, L, Bajunirwe, F, Twesigye, R, Borrow, R, Froholm, O, Batwala, V, Aaberge, I, Rottingen, J, Piola, P, Caugant, D
Format:	Journal article
Published:	2006

Similar Items

Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in Uganda
by: Guerin, P, et al.
Published: (2008)

Avidity of serogroup A meningococcal IgG antibodies after immunization with different doses of a tetravalent A/C/Y/W135 polysaccharide vaccine.
by: Bårnes, G, et al.
Published: (2011)

Pharyngeal carriage of Neisseria meningitidis in 2-19-year-old individuals in Uganda.
by: Caugant, D, et al.
Published: (2006)

Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease
by: Pei-Lan Shao, et al.
Published: (2009-07-01)

Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children
by: Samba O. Sow, et al.
Published: (2023-08-01)

Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.
by: Pace, D, et al.
Published: (2007)

W135 Meningococcal Disease in Africa
by: Pollard, A, et al.
Published: (2003)

W135 Meningococcal Disease in Africa
by: Andrew J. Pollard, et al.
Published: (2003-11-01)

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.
by: Snape, MD, et al.
Published: (2008)

Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study.
by: Nathan, N, et al.
Published: (2005)

Serogroup W135 Meningococcal Disease, The Gambia, 2012
by: M. Jahangir Hossain, et al.
Published: (2013-09-01)

MEMORY B CELL RESPONSES FOLLOWING IMMUNISATION WITH POLYSACCHARIDE AND CONJUGATE QUADRIVALENT MENINGOCOCCAL ACYW135 VACCINES IN HEALTHY ADULT VOLUNTEERS
by: Maheshi, R, et al.
Published: (2010)

Comparative Transcriptome Profiling of mRNA and lncRNA of Mouse Spleens Inoculated with the Group ACYW135 Meningococcal Polysaccharide Vaccine
by: Nan Zhu, et al.
Published: (2023-07-01)

A Case of Meningococcal Meningitis Due to W135 Strain
by: Aliye BAŞTUĞ, et al.
Published: (2008-03-01)

Serogroup W-135 Meningococcal Disease during the Hajj, 2000
by: Jairam R. Lingappa, et al.
Published: (2003-06-01)

Cost-effectiveness of meningococcal vaccination of Norwegian teenagers with a quadrivalent ACWY conjugate vaccine
by: Sara Viksmoen Watle, et al.
Published: (2021-08-01)

Meningococcal disease. Meningococcal conjugate polysaccharide vaccines and new generation vaccines. Report 3
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Instruction for Medical Use Drug MENAKTRA (Vaccine Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Conjugated to Diphtheria Toxoid)
by: Editorial Article
Published: (2016-04-01)

Meningococcal polysaccharide-protein conjugate vaccines.
by: Snape, MD, et al.
Published: (2005)

Reconsideration of the use of meningococcal polysaccharide vaccine.
by: Granoff, D, et al.
Published: (2007)

Epidemic Meningococcal Meningitis, Cameroon
by: D. Massenet, et al.
Published: (2011-11-01)

Meningitis serogroup W135 outbreak, Burkina Faso, 2002.
by: Nathan, N, et al.
Published: (2007)

The Course of Generalized Meningococcal Infection Caused by Meningococcus Serogroup W135
by: M. V. Ivanova, et al.
Published: (2016-11-01)

Serogroup W135 Meningococcal Meningitis, Northern Cameroon, 2007–2008
by: Denis Massenet, et al.
Published: (2009-02-01)

Meningococcal W135 Disease Vaccination Intent, the Netherlands, 2018–2019
by: Liesbeth Claassen Marion de Vries, et al.
Published: (2020-07-01)

Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines
by: Paolo Bonanni, et al.
Published: (2020-06-01)

Meningococcal disease. Polysaccharide meningococcal vaccines. The historical aspects and the current state of vaccine development. Report 2
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

Meningococcal vaccine. From capsular polysaccharides of microbes to proteases
by: A P Alliluyev, et al.
Published: (2012-12-01)

Determination of antibody responses to meningococcal antigens by ELISA.
by: Rosenqvist, E, et al.
Published: (2001)

Safety of Combination of a Tetravalent Meningococcal Conjugate Vaccine Against Serogroups A, C, Y, W-135 With Other Vaccine Preparations: a Prospective Study of a Series of Cases Among Healthy Children and Children With Various Health Abnormalities
by: Leyla S. Namazova-Baranova, et al.
Published: (2017-06-01)

B cell responses to conjugate and polysaccharide meningococcal vaccines
by: Ramasamy, M
Published: (2012)

Outbreak of Serogroup W135 Meningococcal Disease after the Hajj Pilgrimage, Europe, 2000
by: Jean-François Aguilera, et al.
Published: (2002-08-01)

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection
by: Ray Borrow, et al.
Published: (2017-04-01)

The important lessons lurking in the history of meningococcal epidemiology
by: Ray Borrow, et al.
Published: (2024-12-01)

Serogroup X in Meningococcal Disease, Western Kenya
by: Sadiki Materu, et al.
Published: (2007-06-01)

Meningococcal virulence in zebrafish embryos depends on capsule polysaccharide structure
by: Kim Schipper, et al.
Published: (2022-09-01)

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
by: Hedari CP, et al.
Published: (2014-04-01)

Meningococcal Carriage among Household Contacts of Patients with Invasive Meningococcal Disease in Kathmandu, Nepal: A Longitudinal Study
by: Supriya Sharma, et al.
Published: (2021-06-01)

T-cell responses against meningococcal antigens.
by: Næss, L, et al.
Published: (2001)

Genomic analysis of the evolution and global spread of hyper-invasive meningococcal lineage 5.
by: Harrison, O, et al.
Published: (2015)